Journal:
The New England Journal of Medicine
The New England Journal of Medicine
Línea de investigación:
L5. Evaluación socioeconómica para la mitigación del riesgo de infraestructura crítica
L5. Evaluación socioeconómica para la mitigación del riesgo de infraestructura crítica
Otros autores:
Alejandro Jara, Ph.D., ¡ Cecilia González, M.D., Fabio Paredes, M.Sc., Tomás Fontecilla, M.Sc., Gonzalo Jara, B.S.E., Alejandra Pizarro, M.D., Johanna Acevedo, M.S., Katherinne Leo, B.S.E., Francisco Leon, M.B.A., Carlos Sans, B.S.E., Paulina Leighton, B.S.E., et al.
Alejandro Jara, Ph.D., ¡ Cecilia González, M.D., Fabio Paredes, M.Sc., Tomás Fontecilla, M.Sc., Gonzalo Jara, B.S.E., Alejandra Pizarro, M.D., Johanna Acevedo, M.S., Katherinne Leo, B.S.E., Francisco Leon, M.B.A., Carlos Sans, B.S.E., Paulina Leighton, B.S.E., et al.
Fecha:
2021
2021
Keywords publicación:
VACCINESVIRAL, INFECTIONS
VACCINESVIRAL, INFECTIONS
Abstract:
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021.
Fecha:
2021
2021
